Enhancing effects of agelasphin-11 on natural killer cell activities of normal and tumor-bearing mice. 1996

E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd, Gunma, Japan.

Agelasphin-11 (AGL-11), a novel alpha-galactosylceramide isolated from an extract of a marine sponge, Agelas mauritianus, markedly prolonged the life span of mice intraperitoneally inoculated with B16 cells. Since AGL-11 did not show any direct cytotoxic activity against B16 cells, this compound is considered to be a biological response modifier (BRM). We focused on the enhancing effect of this compound on in vivo natural killer (NK) cell activity because several BRMs have already been determined to enhance the in vivo natural killer (NK) cell activity. When we evaluated the enhancing activity of AGL-11 using normal mice, AGL-11 enhanced in vivo NK cell activity more potently than Poly I:C, which is a positive control. In addition, we examined the effect of this compound on the NK cell activity of tumor-bearing mice, and found that AGL-11 recovers the reduced NK cell activity in a tumor-bearing condition to a higher level than that of normal mice. These results suggest that AGL-11 shows antitumor activity by the activation of antitumor effector cells such as NK cells.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D005260 Female Females
D005699 Galactosylceramides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Galactocerebrosides,Galactosyl Ceramide,Galactosyl Ceramides,Galactosylceramide,Ceramide, Galactosyl,Ceramides, Galactosyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
January 1988, Cancer immunology, immunotherapy : CII,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
January 2013, In vivo (Athens, Greece),
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
June 1983, [Osaka Daigaku shigaku zasshi] The journal of Osaka University Dental Society,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
January 1985, Immunology letters,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
March 2000, Proceedings of the National Academy of Sciences of the United States of America,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
July 1983, Clinical immunology and immunopathology,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
January 1983, Nihon geka hokan. Archiv fur japanische Chirurgie,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
September 2012, The journals of gerontology. Series A, Biological sciences and medical sciences,
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
June 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
E Kobayashi, and K Motoki, and T Natori, and T Uchida, and H Fukushima, and Y Koezuka
January 1987, Cancer immunology, immunotherapy : CII,
Copied contents to your clipboard!